• 27780 Citations
19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer

Gelmon, K. A., Cristofanilli, M., Rugo, H. S., DeMichele, A. M., Joy, A. A., Castrellon, A., Sleckman, B., Mori, A., Theall, K. P., Lu, D. R., Huang, X., Bananis, E., Finn, R. S. & Slamon, D. J., Mar 1 2020, In : Breast Journal. 26, 3, p. 368-375 8 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Genetic variants detected using cell-free DNA from blood and tumor samples in patients with inflammatory breast cancer

Winn, J. S., Hasse, Z., Slifker, M., Pei, J., Arisi-Fernandez, S. M., Talarchek, J. N., Obeid, E., Baldwin, D. A., Gong, Y., Ross, E., Cristofanilli, M., Alpaugh, R. K. & Fernandez, S. V., Feb 2 2020, In : International journal of molecular sciences. 21, 4, 1290.

Research output: Contribution to journalArticle

Open Access

Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Pooled analysis from randomized phase 2 and 3 studies

Ettl, J., Im, S. A., Ro, J., Masuda, N., Colleoni, M., Schnell, P., Bananis, E., Lu, D. R., Cristofanilli, M., Rugo, H. S. & Finn, R. S., Mar 12 2020, In : Breast Cancer Research. 22, 1, 27.

Research output: Contribution to journalArticle

Open Access

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers

Bertucci, F., Rypens, C., Finetti, P., Guille, A., Adélaïde, J., Monneur, A., Carbuccia, N., Garnier, S., Dirix, P., Gonçalves, A., Vermeulen, P., Debeb, B. G., Wang, X., Dirix, L., Ueno, N. T., Viens, P., Cristofanilli, M., Chaffanet, M., Birnbaum, D. & Van Laere, S., Mar 1 2020, In : Molecular oncology. 14, 3, p. 504-519 16 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations
Open Access

Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors

Wang, C., Mu, Z., Ye, Z., Zhang, Z., Abu-Khalaf, M. M., Silver, D. P., Palazzo, J. P., Jagannathan, G., Fellin, F. M., Bhattacharya, S., Jaslow, R. J., Tsangaris, T. N., Berger, A., Neupane, M., Cescon, T. P., Lopez, A. M., Yao, K., Chong, W., Lu, B., Myers, R. E. & 5 others, Hou, L., Wei, Q., Li, B., Cristofanilli, M. & Yang, H., Jun 1 2020, In : Breast Cancer Research and Treatment. 181, 3, p. 679-689 11 p.

Research output: Contribution to journalArticle

1 Scopus citations

Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance

Zhou, Z., Song, X., Chi, J. J., Gius, D. R., Huang, Y., Cristofanilli, M. & Wan, Y., Jun 2020, In : Cellular Signalling. 70, 109574.

Research output: Contribution to journalArticle

Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors

Vidula, N., Rich, T. A., Sartor, O., Yen, J., Hardin, A., Nance, T., Lilly, M. B., Nezami, M. A., Patel, S. P., Carneiro, B. A., Fan, A. C., Brufsky, A. M., Parker, B. A., Bridges, B. B., Agarwal, N., Maughan, B. L., Raymond, V. M., Fairclough, S. R., Lanman, R. B., Bardia, A. & 1 others, Cristofanilli, M., Jun 1 2020, In : Clinical Cancer Research. 26, 11, p. 2546-2555 10 p.

Research output: Contribution to journalArticle

1 Scopus citations
2019

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Formisano, L., Lu, Y., Servetto, A., Hanker, A. B., Jansen, V. M., Bauer, J. A., Sudhan, D. R., Guerrero-Zotano, A. L., Croessmann, S., Guo, Y., Ericsson, P. G., Lee, K. M., Nixon, M. J., Schwarz, L. J., Sanders, M. E., Dugger, T. C., Cruz, M. R., Behdad, A., Cristofanilli, M., Bardia, A. & 11 others, O’Shaughnessy, J., Nagy, R. J., Lanman, R. B., Solovieff, N., He, W., Miller, M., Su, F., Shyr, Y., Mayer, I. A., Balko, J. M. & Arteaga, C. L., Dec 1 2019, In : Nature communications. 10, 1, 1373.

Research output: Contribution to journalArticle

Open Access
31 Scopus citations

A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy

Zhou, Z., Feng, Z., Hu, D., Yang, P., Gur, M., Bahar, I., Cristofanilli, M., Gradishar, W. J., Xie, X. Q. & Wan, Y., Jun 2019, In : EBioMedicine. 44, p. 98-111 14 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

A novel strategy to block mitotic progression for targeted therapy

Chi, J. J., Li, H., Zhou, Z., Izquierdo-Ferrer, J., Xue, Y., Wavelet, C. M., Schiltz, G. E., Zhang, B., Cristofanilli, M., Lu, X., Bahar, I. & Wan, Y., Nov 2019, In : EBioMedicine. 49, p. 40-54 15 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer

De Giorgi, U., Mego, M., Scarpi, E., Giordano, A., Giuliano, M., Valero, V., Alvarez, R. H., Ueno, N. T., Cristofanilli, M. & Reuben, J. M., Aug 1 2019, In : Therapeutic Advances in Medical Oncology. 11

Research output: Contribution to journalArticle

Open Access
3 Scopus citations
Open Access
2 Scopus citations

Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA

Ye, Z., Wang, C., Wan, S., Mu, Z., Zhang, Z., Abu-Khalaf, M. M., Fellin, F. M., Silver, D. P., Neupane, M., Jaslow, R. J., Bhattacharya, S., Tsangaris, T. N., Chervoneva, I., Berger, A., Austin, L., Palazzo, J. P., Myers, R. E., Pancholy, N., Toorkey, D., Yao, K. & 10 others, Krall, M., Li, X., Chen, X., Fu, X., Xing, J., Hou, L., Wei, Q., Li, B., Cristofanilli, M. & Yang, H., Jan 2019, In : European Journal of Cancer. 106, p. 133-143 11 p.

Research output: Contribution to journalArticle

8 Scopus citations

Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer

Beck, T. N., Boumber, Y. A., Aggarwal, C., Pei, J., Thrash-Bingham, C., Fittipaldi, P., Vlasenkova, R., Rao, C., Borghaei, H., Cristofanilli, M., Mehra, R., Serebriiskii, I. & Alpaugh, R. K., Jun 19 2019, In : BMC cancer. 19, 1, 603.

Research output: Contribution to journalArticle

Open Access

Circulating Tumor Cells with Epithelial–to–mesenchymal Transition Phenotypes Associated with Inferior Outcomes in Primary Breast Cancer

Mego, M., Karaba, M., Minarik, G., Benca, J., Silvia, J., Sedlackova, T., Manasova, D., Kalavska, K., Pindak, D., Cristofanilli, M., Reuben, J. M. & Mardiak, J., Apr 2019, In : Anticancer research. 39, 4, p. 1829-1837 9 p.

Research output: Contribution to journalArticle

12 Scopus citations

Combined blockade of activating ERBB2 mutations and ER results in synthetic lethality of ERþ/HER2 mutant breast cancer

Croessmann, S., Formisano, L., Kinch, L. N., Gonzalez-Ericsson, P. I., Sudhan, D. R., Nagy, R. J., Mathew, A., Bernicker, E. H., Cristofanilli, M., He, J., Cutler, R. E., Lalani, A. S., Miller, V. A., Lanman, R. B., Grishin, N. V. & Arteaga, C. L., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 277-289 13 p.

Research output: Contribution to journalArticle

11 Scopus citations

Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast Cancer

Dogan, B. E., Yuan, Q., Bassett, R., Guvenc, I., Jackson, E. F., Cristofanilli, M. & Whitman, G. J., May 1 2019, In : Current Problems in Diagnostic Radiology. 48, 3, p. 235-240 6 p.

Research output: Contribution to journalArticle

3 Scopus citations

Comparison of beaming and droplet digital PCR for circulating tumor DNA analysis

O’Leary, B., Hrebien, S., Beaney, M., Fribbens, C., Garcia-Murillas, I., Jiang, J., Li, Y., Bartlett, C. H., André, F., Loibl, S., Loi, S., Cristofanilli, M. & Turner, N. C., Jan 1 2019, In : Clinical chemistry. 65, 11, p. 1405-1413 9 p.

Research output: Contribution to journalArticle

4 Scopus citations

Current state of clinical trials in breast cancer brain metastases

Fares, J., Kanojia, D., Cordero, A., Rashidi, A., Miska, J., Schwartz, C. W., Savchuk, S., Ahmed, A. U., Balyasnikova, I. V., Cristofanilli, M., Gradishar, W. J. & Lesniak, M. S., Sep 20 2019, In : Neuro-Oncology Practice. 6, 5, p. 392-401 10 p.

Research output: Contribution to journalArticle

8 Scopus citations

Cyclin E1 expression and palbociclib efficacy in previously treated hormone receptor-positive metastatic breast cancer

Turner, N. C., Liu, Y., Zhu, Z., Loi, S., Colleoni, M., Loibl, S., DeMichele, A., Harbeck, N., André, F., Bayar, M. A. M., Michiels, S. P., Zhang, Z., Giorgetti, C., Arnedos, M., Bartlett, C. H. & Cristofanilli, M., Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1169-1178 10 p.

Research output: Contribution to journalArticle

Open Access
40 Scopus citations

Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer

Cohen, E. N., Fouad, T. M., Lee, B. N., Arun, B. K., Liu, D., Tin, S., Gutierrez Barrera, A. M., Miura, T., Kiyokawa, I., Yamashita, J., Alvarez, R. H., Valero, V., Woodward, W. A., Shen, Y., Ueno, N. T., Cristofanilli, M. & Reuben, J. M., Aug 15 2019, In : Breast Cancer Research and Treatment. 176, 3, p. 545-556 12 p.

Research output: Contribution to journalArticle

3 Scopus citations

Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis

Giuliano, M., Schettini, F., Rognoni, C., Milani, M., Jerusalem, G., Bachelot, T., De Laurentiis, M., Thomas, G., De Placido, P., Arpino, G., De Placido, S., Cristofanilli, M., Giordano, A., Puglisi, F., Pistilli, B., Prat, A., Del Mastro, L., Venturini, S. & Generali, D., Oct 2019, In : The Lancet Oncology. 20, 10, p. 1360-1369 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in patient-derived breast cancer models

Liu, X., Taftaf, R., Kawaguchi, M., Chang, Y. F., Chen, W., Entenberg, D., Zhang, Y., Gerratana, L., Huang, S., Patel, D. B., Tsui, E., Adorno-Cruz, V., Chirieleison, S. M., Cao, Y., Harney, A. S., Patel, S., Patsialou, A., Shen, Y., Avril, S., Gilmore, H. L. & 5 others, Lathia, J. D., Abbott, D. W., Cristofanilli, M., Condeelis, J. S. & Liu, H., Jan 2019, In : Cancer discovery. 9, 1, p. 96-113 18 p.

Research output: Contribution to journalArticle

35 Scopus citations

Long-term pooled safety analysis of palbociclib in combination with endocrine therapy for HR1/HER2- Advanced breast cancer

Diéras, V., Rugo, H. S., Schnell, P., Gelmon, K., Cristofanilli, M., Loi, S., Colleoni, M., Lu, D. R., Mori, A., Gauthier, E., Bartlett, C. H., Slamon, D. J., Turner, N. C. & Finn, R. S., 2019, In : Journal of the National Cancer Institute. 111, 4, djy109.

Research output: Contribution to journalArticle

Open Access
12 Scopus citations

Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial

Jiang, Z., Li, W., Hu, X., Zhang, Q., Sun, T., Cui, S., Wang, S., Ouyang, Q., Yin, Y., Geng, C., Tong, Z., Cheng, Y., Pan, Y., Sun, Y., Wang, H., Ouyang, T., Gu, K., Feng, J., Wang, X., Wang, S. & 5 others, Liu, T., Gao, J., Cristofanilli, M., Ning, Z. & Lu, X., Jun 2019, In : The Lancet Oncology. 20, 6, p. 806-815 10 p.

Research output: Contribution to journalArticle

16 Scopus citations
2018

Acquired resistance to poly (ADP-ribose) polymerase inhibitor olaparib in BRCA2-associated prostate cancer resulting from biallelic BRCA2 reversion mutations restores both germline and somatic loss-of-function mutations

Carneiro, B. A., Collier, K. A., Nagy, R. J., Pamarthy, S., Sagar, V., Fairclough, S., Odegaard, J., Lanman, R. B., Costa, R., Taxter, T., Kuzel, T. M., Fan, A., Chae, Y. K., Cristofanilli, M., Hussain, M. H., Abdulkadir, S. A. & Giles, F. J., Jan 1 2018, In : JCO Precision Oncology. 2

Research output: Contribution to journalArticle

14 Scopus citations

Anaplastic lymphoma kinase mutation (ALK F1174C) in small cell carcinoma of the prostate and molecular response to alectinib

Carneiro, B. A., Pamarthy, S., Shah, A. N., Sagar, V., Unno, K., Han, H. Y., Yang, X. J., Costa, R. B., Nagy, R. J., Lanman, R. B., Kuzel, T. M., Ross, J. S., Gay, L., Elvin, J. A., Ali, S. M., Cristofanilli, M., Chae, Y. K., Giles, F. J. & Abdulkadir, S. A., Jun 15 2018, In : Clinical Cancer Research. 24, 12, p. 2732-2739 8 p.

Research output: Contribution to journalArticle

7 Scopus citations

Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer

Brisard, D., Eckerdt, F., Marsh, L. A., Blyth, G. T., Jain, S., Cristofanilli, M., Horiuchi, D. & Platanias, L. C., Dec 1 2018, In : Oncotarget. 9, 99, p. 37305-37318 14 p.

Research output: Contribution to journalArticle

2 Scopus citations

A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer

Santa-Maria, C. A., Kato, T., Park, J. H., Kiyotani, K., Rademaker, A., Shah, A. N., Gross, L., Blanco, L. Z., Jain, S., Flaum, L., Tellez, C., Stein, R., Uthe, R., Gradishar, W. J., Cristofanilli, M., Nakamura, Y. & Giles, F. J., Apr 10 2018, In : Oncotarget. 9, 27, p. 18985-18996 12 p.

Research output: Contribution to journalArticle

19 Scopus citations

Association of circulating tumor cell status with benefit of radiotherapy and survival in early-stage breast cancer

Goodman, C. R., Seagle, B. L. L., Friedl, T. W. P., Rack, B., Lato, K., Fink, V., Cristofanilli, M., Donnelly, E. D., Janni, W., Shahabi, S. & Strauss, J. B., Aug 2018, In : JAMA Oncology. 4, 8, e180163.

Research output: Contribution to journalArticle

35 Scopus citations

Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model

Simone, B. A., Palagani, A., Strickland, K., Ko, K., Jin, L., Lim, M. K., Dan, T. D., Sarich, M., Monti, D. A., Cristofanilli, M. & Simone, N. L., Jul 3 2018, In : Cell Cycle. 17, 13, p. 1536-1544 9 p.

Research output: Contribution to journalArticle

4 Scopus citations

CCR5 Governs DNA damage repair and breast cancer stem cell expansion

Jiao, X., Velasco-Velazquez, M. A., Wang, M., Li, Z., Rui, H., Peck, A. R., Korkola, J. E., Chen, X., Xu, S., DuHadaway, J. B., Guerrero-Rodriguez, S., Addya, S., Sicoli, D., Mu, Z., Zhang, G., Stucky, A., Zhang, X., Cristofanilli, M., Fatatis, A., Gray, J. W. & 3 others, Zhong, J. F., Prendergast, G. C. & Pestell, R. G., Apr 1 2018, In : Cancer Research. 78, 7, p. 1657-1671 15 p.

Research output: Contribution to journalArticle

29 Scopus citations

Cell-free DNA and circulating tumor cells: Comprehensive liquid biopsy analysis in advanced breast cancer

Rossi, G., Mu, Z., Rademaker, A. W., Austin, L. K., Strickland, K. S., Costa, R. L. B., Nagy, R. J., Zagonel, V., Taxter, T. J., Behdad, A., Wehbe, F. H., Platanias, L. C., Gradishar, W. J. & Cristofanilli, M., Feb 1 2018, In : Clinical Cancer Research. 24, 3, p. 560-568 9 p.

Research output: Contribution to journalArticle

43 Scopus citations

Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases

Turner, N. C., Finn, R. S., Martin, M., Im, S. A., DeMichele, A., Ettl, J., Diéras, V., Moulder, S., Lipatov, O., Colleoni, M., Cristofanilli, M., Lu, D. R., Mori, A., Giorgetti, C., Iyer, S., Huang Bartlett, C. & Gelmon, K. A., Mar 1 2018, In : Annals of Oncology. 29, 3, p. 669-680 12 p.

Research output: Contribution to journalArticle

24 Scopus citations

Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer

Ding, Q., Wang, Y., Zuo, Z., Gong, Y., Krishnamurthy, S., Li, C. W., Lai, Y. J., Wei, W., Wang, J., Manyam, G. C., Diao, L., Zhang, X., Lin, F., Symmans, W. F., Sun, L., Liu, C. G., Liu, X., Debeb, B. G., Ueno, N. T., Harano, K. & 4 others, Alvarez, R. H., Wu, Y., Cristofanilli, M. & Huo, L., Jul 2018, In : Human pathology. 77, p. 121-129 9 p.

Research output: Contribution to journalArticle

6 Scopus citations

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

O'Leary, B., Hrebien, S., Morden, J. P., Beaney, M., Fribbens, C., Huang, X., Liu, Y., Bartlett, C. H., Koehler, M., Cristofanilli, M., Garcia-Murillas, I., Bliss, J. M. & Turner, N. C., Dec 1 2018, In : Nature communications. 9, 1, 896.

Research output: Contribution to journalArticle

93 Scopus citations
14 Scopus citations

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing

Trosman, J. R., Weldon, C. B., Gradishar, W. J., Benson III, A. B., Cristofanilli, M., Kurian, A. W., Ford, J. M., Balch, A., Watkins, J. & Phillips, K. A., Sep 2018, In : Value in Health. 21, 9, p. 1062-1068 7 p.

Research output: Contribution to journalArticle

5 Scopus citations

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications

Toss, A., Piacentini, F., Cortesi, L., Artuso, L., Bernardis, I., Parenti, S., Tenedini, E., Ficarra, G., Maiorana, A., Iannone, A., Omarini, C., Moscetti, L., Cristofanilli, M., Federico, M. & Tagliafico, E., Aug 1 2018, In : Oncotarget. 9, 60, p. 31606-31619 14 p.

Research output: Contribution to journalArticle

2 Scopus citations

Identification of incidental germline mutations in patients with advanced solid tumors who underwent cell-free circulating tumor DNA sequencing

Slavin, T. P., Banks, K. C., Chudova, D., Oxnard, G. R., Odegaard, J. I., Nagy, R. J., Tsang, K. W. K., Neuhausen, S. L., Gray, S. W., Cristofanilli, M., Rodriguez, A. A., Bardia, A., Leyland-Jones, B., Janicek, M. F., Lilly, M., Sonpavde, G., Lee, C. E., Lanman, R. B., Meric-Bernstam, F., Kurzrock, R. & 1 others, Weitzel, J. N., Dec 10 2018, In : Journal of Clinical Oncology. 36, 35, p. 3459-3465 7 p.

Research output: Contribution to journalArticle

20 Scopus citations

Impeding circulating tumor cell reseeding decelerates metastatic progression and potentiates chemotherapy

Qian, C., Worrede-Mahdi, A., Shen, F., DiNatale, A., Kaur, R., Zhang, Q., Cristofanilli, M., Meucci, O. & Fatatis, A., Dec 1 2018, In : Molecular Cancer Research. 16, 12, p. 1844-1854 11 p.

Research output: Contribution to journalArticle

1 Scopus citations

International consensus on the clinical management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer research program 10th anniversary conference

Ueno, N. T., Espinosa Fernandez, J. R., Cristofanilli, M., Overmoyer, B., Rea, D., Berdichevski, F., El-Shinawi, M., Bellon, J., Le-Petross, H. T., Lucci, A., Babiera, G., DeSnyder, S. M., Teshome, M., Chang, E., Lim, B., Krishnamurthy, S., Stauder, M. C., Parmar, S., Mohamed, M. M., Alexander, A. & 2 others, Valero, V. & Woodward, W. A., 2018, In : Journal of Cancer. 9, 8, p. 1437-1447 11 p.

Research output: Contribution to journalArticle

20 Scopus citations

NQO1 regulates mitotic progression and response to mitotic stress through modulating SIRT2 activity

Kang, H. J., Song, H. Y., Ahmed, M. A., Guo, Y., Zhang, M., Chen, C., Cristofanilli, M., Horiuchi, D. & Vassilopoulos, A., Oct 2018, In : Free Radical Biology and Medicine. 126, p. 358-371 14 p.

Research output: Contribution to journalArticle

1 Scopus citations

Overall survival (OS) with palbociclib plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Analyses from PALOMA-3

Cristofanilli, M., Slamon, D. J., Ro, J., Bondarenko, I., Im, S. A., Masuda, N., Colleoni, M., DeMichele, A., Loi, S., Verma, S., Iwata, H., Harbeck, N., Loibl, S., André, F., Puyana Theall, K., Huang, X., Giorgetti, C., Huang Bartlett, C. & Turner, N. C., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii708

Research output: Contribution to journalArticle

Open Access

Overall survival with palbociclib and fulvestrant in advanced breast cancer

Turner, N. C., Slamon, D. J., Ro, J., Bondarenko, I., Im, S. A., Masuda, N., Colleoni, M., DeMichele, A., Loi, S., Verma, S., Iwata, H., Harbeck, N., Loibl, S., André, F., Theall, K. P., Huang, X., Giorgetti, C., Bartlett, C. H. & Cristofanilli, M., Nov 15 2018, In : New England Journal of Medicine. 379, 20, p. 1926-1936 11 p.

Research output: Contribution to journalArticle

160 Scopus citations
21 Scopus citations

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3

Cristofanilli, M., DeMichele, A., Giorgetti, C., Turner, N. C., Slamon, D. J., Im, S. A., Masuda, N., Verma, S., Loi, S., Colleoni, M., Theall, K. P., Huang, X., Liu, Y. & Bartlett, C. H., Nov 2018, In : European Journal of Cancer. 104, p. 21-31 11 p.

Research output: Contribution to journalArticle

13 Scopus citations

The genetic landscape and clonal evolution of breast cancer resistance to palbociclib plus fulvestrant in the PALOMA-3 trial

O’leary, B., Cutts, R. J., Liu, Y., Hrebien, S., Huang, X., Fenwick, K., André, F., Loibl, S., Loi, S., Garcia-Murillas, I., Cristofanilli, M., Bartlett, C. H. & Turner, N. C., Nov 2018, In : Cancer discovery. 8, 11, p. 1390-1403 14 p.

Research output: Contribution to journalArticle

75 Scopus citations